出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年12月
Microcarriers Market – Global Forecast to 2028
マイクロキャリア市場 : 製品、機器（シングルユースバイオリアクター、SSB、セルカウンター、培養容器、濾過）、消耗品（培地、試薬）、ビーズ（コラーゲン、カチオン）、用途（ワクチン、細胞＆遺伝子治療）、エンドユーザー – 2028年までの世界予測
Microcarriers Market by Product (Equipment (Single Use Bioreactor, SSB, Cell Counter, Culture Vessel, Filtration), Consumables (Media, Reagent), Beads (Collagen, Cationic), Application (Vaccine, Cell & Gene Therapy), End User – Global Forecast to 2028
| ページ数 | 412 |
| 図表数 | 551 |
| 種別 | 英文調査報告書 |
| 価格 |
Report Overview
The microcarriers market is projected to reach USD 3.3 billion by 2028 from an estimated USD 2.0 billion in 2023, at a CAGR of 10.0% during the forecast period. The growth of this market can be attributed to rising investments in cell & gene therapy research and growing technological advancements in single-use technologies.
“The consumables segment accounted for the largest share by product in 2022.”
Consumables segment accounted for the largest share of product in the global microcarriers market in 2022. Various factors such as booming biopharmaceutical sector, and growing investments and government fundings for the advancement of technologies are driving the demand for consumables in the microcarriers market. Additionally, rising demand for high-quality reagents and media for cell therapies is promoting the growth of this market. Furthermore, the market share of the consumables market is expected to grow simultaneously with the growing cell-based research activities.
“The Asia Pacific region is growing in the microcarriers market during the forecast period of 2023-2028.”
The Asia Pacific region is expected to grow at the highest growth rate during the forecast period. Various factors including growing adoption of advanced technologies and booming healthcare sector are propelling the growth of microcarriers market in the region. The rising investments and geographic expansion of microcarriers by prominent players are promoting the growth of the microcarriers market. For instance, in December 2022, Thermo Fisher Scientific opened an 860,000 square-foot facility in Hangzhou, China, which is the company’s first single-use manufacturing site in the Asia-Pacific region. The facility offers clinical and commercial drug substance and drug product capabilities, housing Thermo Fisher’s HyPerforma single-use bioreactors and associated single-use equipment to a 2,000 L scale, catering to the demand for biologics production capabilities from customers in the region.
The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 60% and Demand Side 40%
• By Designation: Managers – 45%, CXO & Directors – 30%, and Executives – 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10% and Middle East & Africa- 5%
List of Companies Profiled in the Report:
• Thermo Fisher Scientific Inc. (US)
• Sartorius AG (Germany)
• Danaher Corporation (US)
• Merck KGaA (Germany)
• Corning Incorporated (US)
• FUJIFILM Holdings Corporation (Japan)
• BD (US)
• Eppendorf SE (Germany)
• Lonza (Switzerland)
• Getinge AB (Sweden)
• ChemoMetec (Denmark)
• Esco Lifesciences Group Ltd (Singapore)
• Entegris (US)
• bbi-biotech GmbH (Germany)
• STEMCELL Technologies (Canada)
• Stobbe Group (Denmark)
• Distek, Inc. (US)
• Bionet (Spain)
• G&G Technologies, Inc. (US)
• Tantti (Taiwan)
• Kühner AG (Switzerland)
• PBS Biotech, Inc. (US)
• REPROCELL Inc. (Japan)
• Meissner Filtration Products, Inc. (US)
• Smart MCs PTY LTD (Australia)
Research Coverage:
This research report categorizes the microcarriers market by product (consumables (media (serum-based media, serum-free media, and other media), reagents, microcarrier beads (cationic beads, collagen-coated beads, protein-coated beads, untreated beads, and other microcarrier beads), and other comsumables) and equipment (bioreactors (single-use bioreactors and stainless-steel bioreactors), culture vessels, filtration and separation equipment, cell counters, and other equipment), application (biopharmaceutical production (vaccine production and therapeutic production), tissue engineering and regenerative medicine (cell and gene therapy, and other tissue engineering and regenerative medicine application), and other applications), and end user (pharmaceutical & biotechnology companies, contract resaerch organizations and contract manufacturing organizations, academic research institutes, and cell banks)
The report’s scope encompasses detailed information regarding major influencing factors such as drivers, trends, challenges, and opportunities shaping the growth of the microcarriers market. A comprehensive analysis of key industry players has been conducted to offer insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. The report also covers recent developments, including new product launches, mergers, and acquisitions, microcarriers market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall microcarriers market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (growing adoption of microcarriers for cell-based vaccine production, technological advancements to support microcarrier-based cell production), restraints (High cost of cell biology research), opportunities (rising demand for 3D cell culture), and challenges (high costs associated with serum-free media) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the microcarriers market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the microcarriers market
• Competitive Assessment: Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), Danaher Corporation, (US), Merck KGaA (Germany), Corning Incorporated (US), FUJIFILM Holdings Corporation (Japan), BD (US), Eppendorf SE (Germany), Lonza (Switzerland), Getinge AB (Sweden), ChemoMetec (Denmark), among others
Table of Contents
1 INTRODUCTION 52
1.1 STUDY OBJECTIVES 52
1.2 MARKET DEFINITION 52
1.2.1 INCLUSIONS AND EXCLUSIONS 53
1.3 MARKET SEGMENTATION 54
1.3.1 MARKET SCOPE 54
1.3.2 YEARS CONSIDERED 56
1.3.3 CURRENCY CONSIDERED 56
1.4 STAKEHOLDERS 56
1.5 LIMITATIONS 57
1.6 SUMMARY OF CHANGES 57
1.7 RECESSION IMPACT 58
2 RESEARCH METHODOLOGY 59
2.1 RESEARCH DATA 59
FIGURE 1 RESEARCH DESIGN 59
2.1.1 SECONDARY DATA 60
2.1.2 PRIMARY DATA 60
FIGURE 2 MICROCARRIERS MARKET: BREAKDOWN OF PRIMARIES 61
2.2 MARKET SIZE ESTIMATION 62
FIGURE 3 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (2022) 62
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022 63
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS (2022) 63
2.2.1 INSIGHTS FROM PRIMARIES 65
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS 65
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 65
2.3 GROWTH FORECAST 66
FIGURE 8 MICROCARRIERS MARKET: CAGR PROJECTIONS 67
FIGURE 9 MICROCARRIERS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 68
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 69
FIGURE 10 DATA TRIANGULATION METHODOLOGY 69
2.5 RESEARCH ASSUMPTIONS 70
2.6 RISK ANALYSIS 70
2.7 RECESSION IMPACT ANALYSIS 70
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH) 70
TABLE 2 US: HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 71
TABLE 3 US: HEALTH EXPENDITURE, 2023–2030 (USD MILLION) 71
3 EXECUTIVE SUMMARY 72
FIGURE 11 MICROCARRIERS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 72
FIGURE 12 MICROCARRIERS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 73
FIGURE 13 MICROCARRIERS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 73
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MICROCARRIERS MARKET 74
4 PREMIUM INSIGHTS 75
4.1 MICROCARRIERS MARKET OVERVIEW 75
FIGURE 15 INCREASING DEMAND FOR CELL-BASED VACCINES TO DRIVE MARKET DURING FORECAST PERIOD 75
4.2 NORTH AMERICA: MICROCARRIERS MARKET, BY PRODUCT 76
FIGURE 16 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 76
4.3 MICROCARRIERS MARKET, BY END USER 76
FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 76
4.4 MICROCARRIERS MARKET, BY APPLICATION 77
FIGURE 18 BIOPHARMACEUTICAL PRODUCTION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 77
4.5 MICROCARRIERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 77
FIGURE 19 ASIA PACIFIC SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 77
5 MARKET OVERVIEW 78
5.1 INTRODUCTION 78
5.2 MARKET DYNAMICS 78
FIGURE 20 MICROCARRIERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 78
TABLE 4 MICROCARRIERS MARKET: IMPACT ANALYSIS 79
5.2.1 DRIVERS 79
5.2.1.1 Growing adoption of microcarriers for cell-based vaccine production 79
5.2.1.2 Technological advancements to support microcarrier-based cell production 80
5.2.1.3 Rising investments in cell & gene therapy research 81
TABLE 5 FUNDING INVESTMENTS IN CELL & GENE THERAPY 82
FIGURE 21 TOTAL FUNDING INCURRED THROUGH SERIES A AND SEED FINANCINGS FOR GENE, CELL, AND RNA THERAPY COMPANIES (Q2 2022−Q2 2023) (USD MILLION) 83
5.2.1.4 Growing preference for single-use technologies 84
5.2.1.5 Increasing R&D spending for biopharmaceutical production 84
FIGURE 22 PHARMACEUTICAL R&D SPENDING (USD BILLION) (2014–2028) 85
5.2.2 RESTRAINTS 85
5.2.2.1 High cost of cell biology research 85
5.2.2.2 Limitations in high-density cell culture production 86
5.2.3 OPPORTUNITIES 86
5.2.3.1 Rising demand for 3D cell culture 86
5.2.3.2 Growing demand for mAbs and biosimilars 87
TABLE 6 MABS APPROVED FOR THERAPEUTIC USE BY US FDA (2021–2023) 88
FIGURE 23 NUMBER OF ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN US/EU (2012−2022) 90
FIGURE 24 NUMBER OF BIOSIMILARS APPROVED AND LAUNCHED (2015−2023) 90
5.2.3.3 High-growth potential of emerging economies 91
5.2.4 CHALLENGES 92
5.2.4.1 High costs associated with serum-free media 92
5.2.4.2 Microcarrier-cell detachment 92
5.3 PORTER’S FIVE FORCES ANALYSIS 93
TABLE 7 MICROCARRIERS MARKET: PORTER’S FIVE FORCES ANALYSIS 93
5.3.1 THREAT OF NEW ENTRANTS 93
5.3.2 THREAT OF SUBSTITUTES 93
5.3.3 BARGAINING POWER OF SUPPLIERS 93
5.3.4 BARGAINING POWER OF BUYERS 93
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 94
5.4 ECOSYSTEM ANALYSIS 94
TABLE 8 MICROCARRIERS MARKET: ROLE IN ECOSYSTEM 94
5.5 SUPPLY CHAIN ANALYSIS 95
FIGURE 25 MICROCARRIERS MARKET: SUPPLY CHAIN ANALYSIS 96
5.6 VALUE CHAIN ANALYSIS 96
FIGURE 26 MICROCARRIERS MARKET: VALUE CHAIN ANALYSIS 96
5.7 REGULATORY LANDSCAPE 98
5.7.1 REGULATORY ANALYSIS 98
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 12 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
5.7.3 REGULATORY SCENARIO 103
TABLE 13 MICROCARRIERS MARKET: REGULATORY GUIDELINES 103
5.8 PRICING ANALYSIS 105
5.8.1 AVERAGE SELLING PRICE OF MICROCARRIER EQUIPMENT AND CONSUMABLES 105
TABLE 14 AVERAGE SELLING PRICE OF MICROCARRIER CELL CULTURE EQUIPMENT AND CONSUMABLES, BY KEY PLAYER (USD) 105
5.8.2 AVERAGE SELLING PRICE OF MICROCARRIER PRODUCTS, BY REGION 107
TABLE 15 AVERAGE SELLING PRICE OF MICROCARRIER CELL CULTURE PRODUCTS, BY REGION (USD) 107
TABLE 16 AVERAGE SELLING PRICE OF SINGLE-USE ASSEMBLIES, BY REGION (USD) 107
5.9 TECHNOLOGICAL ANALYSIS 107
5.9.1 SINGLE-USE TECHNOLOGIES 107
TABLE 17 COMPARISON OF SINGLE-USE AND STAINLESS-STEEL BIOREACTORS 109
5.9.2 MICROCARRIER BEADS 109
5.10 PATENT ANALYSIS 110
FIGURE 27 PATENTS GRANTED IN MICROCARRIERS MARKET (JANUARY 2013– OCTOBER 2023) 111
TABLE 18 INDICATIVE LIST OF PATENTS IN MICROCARRIERS MARKET 111
5.11 KEY CONFERENCES AND EVENTS IN 2023–2024 113
TABLE 19 MICROCARRIERS MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS 113
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES 114
FIGURE 28 REVENUE SHIFT & NEW POCKETS FOR MICROCARRIER PROVIDERS 115
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 115
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 115
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROCARRIERS 115
5.13.2 BUYING CRITERIA FOR END USERS 116
FIGURE 30 KEY BUYING CRITERIA FOR END USERS 116
6 MICROCARRIERS MARKET, BY PRODUCT 118
6.1 INTRODUCTION 119
TABLE 20 MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 119
6.2 CONSUMABLES 119
TABLE 21 CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 22 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 23 EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 24 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 25 LATIN AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 26 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 121
TABLE 27 CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 121
6.2.1 MEDIA 122
TABLE 28 MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 122
TABLE 29 NORTH AMERICA: MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 30 EUROPE: MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 31 ASIA PACIFIC: MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 32 LATIN AMERICA: MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 33 MIDDLE EAST & AFRICA: MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 124
TABLE 34 MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 124
6.2.1.1 Serum-based media 125
6.2.1.1.1 Wide usage in research & biopharma applications to fuel market 125
TABLE 35 SERUM-BASED MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 36 NORTH AMERICA: SERUM-BASED MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 37 EUROPE: SERUM-BASED MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 38 ASIA PACIFIC: SERUM-BASED MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 39 LATIN AMERICA: SERUM-BASED MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 40 MIDDLE EAST & AFRICA: SERUM-BASED MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 127
6.2.1.2 Serum-free media 128
6.2.1.2.1 Rising demand for regenerative medicine to propel market 128
TABLE 41 SERUM-FREE MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 129
TABLE 42 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 43 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 44 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 45 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 46 MIDDLE EAST & AFRICA: SERUM-FREE MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 130
6.2.1.3 Other media 131
TABLE 47 OTHER MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 131
TABLE 48 NORTH AMERICA: OTHER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 49 EUROPE: OTHER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 50 ASIA PACIFIC: OTHER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 51 LATIN AMERICA: OTHER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 52 MIDDLE EAST & AFRICA: OTHER MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 133
6.2.2 REAGENTS 133
6.2.2.1 Ability to maintain cell metabolism and protect tissues from damage to drive market 133
TABLE 53 REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 54 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 55 EUROPE: REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 56 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 57 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 58 MIDDLE EAST & AFRICA: REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 136
6.2.3 MICROCARRIER BEADS 136
TABLE 59 MICROCARRIER BEADS OFFERED, BY KEY PLAYER 137
TABLE 60 MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION) 138
TABLE 61 NORTH AMERICA: MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 62 EUROPE: MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 63 ASIA PACIFIC: MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 64 LATIN AMERICA: MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 65 MIDDLE EAST & AFRICA: MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION) 139
TABLE 66 MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
6.2.3.1 Collagen-coated beads 140
6.2.3.1.1 Development of new collagen-coated microcarriers to support market growth 140
TABLE 67 COLLAGEN-COATED MICROCARRIER PRODUCTS OFFERED, BY KEY PLAYER 141
TABLE 68 COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION) 141
TABLE 69 NORTH AMERICA: COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 70 EUROPE: COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 71 ASIA PACIFIC: COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 72 LATIN AMERICA: COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 73 MIDDLE EAST & AFRICA: COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION) 143
6.2.3.2 Cationic beads 144
6.2.3.2.1 Ability to enhance cell interaction to boost demand 144
TABLE 74 CATIONIC MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION) 144
TABLE 75 NORTH AMERICA: CATIONIC MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 76 EUROPE: CATIONIC MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 77 ASIA PACIFIC: CATIONIC MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 78 LATIN AMERICA: CATIONIC MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 79 MIDDLE EAST & AFRICA: CATIONIC MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION) 146
6.2.3.3 Protein-coated beads 146
6.2.3.3.1 Ethical imperatives and regulatory compliance to drive market 146
TABLE 80 PROTEIN-COATED MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION) 147
TABLE 81 NORTH AMERICA: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 82 EUROPE: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 83 ASIA PACIFIC: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 84 LATIN AMERICA: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 85 MIDDLE EAST & AFRICA: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION) 149
6.2.3.4 Untreated beads 149
6.2.3.4.1 Low-cell attachment efficiency to restrain market 149
TABLE 86 UNTREATED MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION) 150
TABLE 87 NORTH AMERICA: UNTREATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 88 EUROPE: UNTREATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 89 ASIA PACIFIC: UNTREATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 90 LATIN AMERICA: UNTREATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 91 MIDDLE EAST & AFRICA: UNTREATED MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION) 151
6.2.3.5 Other microcarrier beads 152
TABLE 92 OTHER MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION) 152
TABLE 93 NORTH AMERICA: OTHER MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 94 EUROPE: OTHER MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 95 ASIA PACIFIC: OTHER MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 96 LATIN AMERICA: OTHER MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 97 MIDDLE EAST & AFRICA: OTHER MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION) 154
6.2.4 OTHER CONSUMABLES 154
TABLE 98 OTHER CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 155
TABLE 99 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 100 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 101 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 102 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 103 MIDDLE EAST & AFRICA: OTHER CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 156
6.3 EQUIPMENT 157
TABLE 104 EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 157
TABLE 105 NORTH AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 106 EUROPE: EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 107 ASIA PACIFIC: EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 108 LATIN AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 109 MIDDLE EAST & AFRICA: EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 159
TABLE 110 EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
6.3.1 BIOREACTORS 159
TABLE 111 BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION) 160
TABLE 112 NORTH AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 113 EUROPE: BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 114 ASIA PACIFIC: BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 115 LATIN AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 116 MIDDLE EAST & AFRICA: BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION) 162
TABLE 117 BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
6.3.1.1 Stainless-steel bioreactors 162
6.3.1.1.1 Utilization in large-scale manufacturing of pharmaceutical drugs to drive market 162
TABLE 118 STAINLESS-STEEL BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION) 163
TABLE 119 NORTH AMERICA: STAINLESS-STEEL BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 120 EUROPE: STAINLESS-STEEL BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 121 ASIA PACIFIC: STAINLESS-STEEL BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 122 LATIN AMERICA: STAINLESS-STEEL BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 123 MIDDLE EAST & AFRICA: STAINLESS-STEEL BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION) 164
6.3.1.2 Single-use bioreactors 165
6.3.1.2.1 Lower operational costs and increased flexibility to boost demand 165
TABLE 124 LIST OF COMMERCIALLY AVAILABLE SINGLE-USE BIOREACTORS, BY KEY PLAYER 166
TABLE 125 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION) 166
TABLE 126 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 127 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 128 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 129 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 130 MIDDLE EAST & AFRICA: SINGLE-USE BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION) 168
6.3.2 CULTURE VESSELS 168
6.3.2.1 Development of 3D dynamic cell culture systems to drive market 168
TABLE 131 CULTURE VESSELS MARKET, BY REGION, 2021–2028 (USD MILLION) 169
TABLE 132 NORTH AMERICA: CULTURE VESSELS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 133 EUROPE: CULTURE VESSELS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 134 ASIA PACIFIC: CULTURE VESSELS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 135 LATIN AMERICA: CULTURE VESSELS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 136 MIDDLE EAST & AFRICA: CULTURE VESSELS MARKET, BY REGION, 2021–2028 (USD MILLION) 171
6.3.3 FILTRATION & SEPARATION EQUIPMENT 171
6.3.3.1 Growing use in bioprocessing industry to boost demand 171
TABLE 137 FILTRATION SYSTEMS OFFERED, BY KEY PLAYER 172
TABLE 138 FILTRATION & SEPARATION EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 173
TABLE 139 NORTH AMERICA: FILTRATION & SEPARATION EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 140 EUROPE: FILTRATION & SEPARATION EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 174
TABLE 141 ASIA PACIFIC: FILTRATION & SEPARATION EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 174
TABLE 142 LATIN AMERICA: FILTRATION & SEPARATION EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 143 MIDDLE EAST & AFRICA: FILTRATION & SEPARATION EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 175
6.3.4 CELL COUNTERS 175
6.3.4.1 Growing adoption of automated cell counters to propel market 175
TABLE 144 CELL COUNTERS OFFERED, BY KEY PLAYER 176
TABLE 145 CELL COUNTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 176
TABLE 146 NORTH AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 176
TABLE 147 EUROPE: CELL COUNTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 148 ASIA PACIFIC: CELL COUNTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 149 LATIN AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 150 MIDDLE EAST & AFRICA: CELL COUNTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 178
6.3.5 OTHER EQUIPMENT 178
TABLE 151 OTHER EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 179
TABLE 152 NORTH AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 179
TABLE 153 EUROPE: OTHER EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 179
TABLE 154 ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 180
TABLE 155 LATIN AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 180
TABLE 156 MIDDLE EAST & AFRICA: OTHER EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 180
7 MICROCARRIERS MARKET, BY APPLICATION 181
7.1 INTRODUCTION 182
TABLE 157 MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 182
7.2 BIOPHARMACEUTICAL PRODUCTION 182
TABLE 158 MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2021–2028 (USD MILLION) 183
TABLE 159 NORTH AMERICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 183
TABLE 160 EUROPE: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 161 ASIA PACIFIC: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 162 LATIN AMERICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 185
TABLE 163 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2021–2028 (USD MILLION) 185
TABLE 164 MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 185
7.2.1 VACCINE PRODUCTION 186
7.2.1.1 Rising incidence of infectious diseases to fuel market 186
TABLE 165 MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY REGION, 2021–2028 (USD MILLION) 187
TABLE 166 NORTH AMERICA: MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 187
TABLE 167 EUROPE: MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 188
TABLE 168 ASIA PACIFIC: MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 188
TABLE 169 LATIN AMERICA: MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 189
TABLE 170 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY REGION, 2021–2028 (USD MILLION) 189
7.2.2 THERAPEUTIC PROTEIN PRODUCTION 189
7.2.2.1 Growing pipeline for innovative therapeutics to support market 189
TABLE 171 MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2021–2028 (USD MILLION) 190
TABLE 172 NORTH AMERICA: MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 173 EUROPE: MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 174 ASIA PACIFIC: MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 192
TABLE 175 LATIN AMERICA: MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 192
TABLE 176 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2021–2028 (USD MILLION) 192
7.2.3 TISSUE ENGINEERING AND REGENERATIVE MEDICINE 193
7.2.3.1 Tissue engineering and regenerative medicine, by therapy type 193
FIGURE 31 REGENERATIVE MEDICINE INVESTMENTS (2017−2023) 194
TABLE 177 MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY REGION, 2021–2028 (USD MILLION) 194
TABLE 178 NORTH AMERICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 195
TABLE 179 EUROPE: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 195
TABLE 180 ASIA PACIFIC: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 196
TABLE 181 LATIN AMERICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 196
TABLE 182 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY REGION, 2021–2028 (USD MILLION) 196
TABLE 183 MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 197
7.2.3.1.1 Cell & gene therapy 197
7.2.3.1.1.1 Rising clinical trials for genetic disorders and cancer to drive market 197
TABLE 184 MICROCARRIERS MARKET FOR CELL & GENE THERAPY, BY REGION, 2021–2028 (USD MILLION) 198
TABLE 185 NORTH AMERICA: MICROCARRIERS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 198
TABLE 186 EUROPE: MICROCARRIERS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 199
TABLE 187 ASIA PACIFIC: MICROCARRIERS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 199
TABLE 188 LATIN AMERICA: MICROCARRIERS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 200
TABLE 189 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR CELL & GENE THERAPY, BY REGION, 2021–2028 (USD MILLION) 200
7.2.3.1.2 Other tissue engineering and regenerative medicine applications 200
TABLE 190 MICROCARRIERS MARKET FOR OTHER TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 201
TABLE 191 NORTH AMERICA: MICROCARRIERS MARKET FOR OTHER TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 201
TABLE 192 EUROPE: MICROCARRIERS MARKET FOR OTHER TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 202
TABLE 193 ASIA PACIFIC: MICROCARRIERS MARKET FOR OTHER TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 202
TABLE 194 LATIN AMERICA: MICROCARRIERS MARKET FOR OTHER TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 203
TABLE 195 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR OTHER TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 203
7.2.3.2 Tissue engineering & regenerative medicine, by cell type 203
TABLE 196 TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY CELL TYPE, 2021–2028 (USD MILLION) 204
7.2.3.2.1 Stem cells 204
7.2.3.2.1.1 Rising activities in stem cell research to fuel market 204
TABLE 197 MICROCARRIERS MARKET FOR STEM CELLS, BY TYPE, 2021–2028 (USD MILLION) 205
7.2.3.2.2 Immune cells 205
7.2.3.2.2.1 Increasing usage of microcarriers for CAR-T cell therapy to boost demand 205
TABLE 198 MICROCARRIERS MARKET FOR IMMUNE CELLS, BY TYPE, 2021–2028 (USD MILLION) 206
7.2.3.2.3 Other cell types 206
7.3 OTHER APPLICATIONS 207
TABLE 199 MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 207
TABLE 200 NORTH AMERICA: MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 207
TABLE 201 EUROPE: MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 208
TABLE 202 ASIA PACIFIC: MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 208
TABLE 203 LATIN AMERICA: MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 209
TABLE 204 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 209
8 MICROCARRIERS MARKET, BY END USER 210
8.1 INTRODUCTION 211
TABLE 205 MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 211
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 211
8.2.1 RISING DEMAND FOR MABS AND BIOSIMILARS TO DRIVE MARKET 211
TABLE 206 MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 212
TABLE 207 NORTH AMERICA: MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 213
TABLE 208 EUROPE: MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 213
TABLE 209 ASIA PACIFIC: MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 214
TABLE 210 LATIN AMERICA: MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 214
TABLE 211 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 214
8.3 CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT MANUFACTURING ORGANIZATIONS 215
8.3.1 PROVISION OF CONTRACT RESEARCH SERVICES TO BOOST DEMAND 215
TABLE 212 MICROCARRIERS MARKET FOR CROS AND CMOS, BY REGION, 2021–2028 (USD MILLION) 216
TABLE 213 NORTH AMERICA: MICROCARRIERS MARKET FOR CROS AND CMOS, BY COUNTRY, 2021–2028 (USD MILLION) 216
TABLE 214 EUROPE: MICROCARRIERS MARKET FOR CROS AND CMOS, BY COUNTRY, 2021–2028 (USD MILLION) 217
TABLE 215 ASIA PACIFIC: MICROCARRIERS MARKET FOR CROS AND CMOS, BY COUNTRY, 2021–2028 (USD MILLION) 217
TABLE 216 LATIN AMERICA: MICROCARRIERS MARKET FOR CROS AND CMOS, BY COUNTRY, 2021–2028 (USD MILLION) 218
TABLE 217 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR CROS AND CMOS, BY REGION, 2021–2028 (USD MILLION) 218
8.4 ACADEMIC & RESEARCH INSTITUTES 218
8.4.1 GROWING COLLABORATIONS BETWEEN BIOPHARMACEUTICAL COMPANIES AND ACADEMIC INSTITUTES TO SUPPORT MARKET 218
TABLE 218 MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 219
TABLE 219 NORTH AMERICA: MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 220
TABLE 220 EUROPE: MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 220
TABLE 221 ASIA PACIFIC: MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 221
TABLE 222 LATIN AMERICA: MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 221
TABLE 223 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 221
8.5 CELL BANKS 222
8.5.1 GROWING FOCUS ON DEVELOPING INNOVATIVE STEM CELL THERAPIES TO PROPEL MARKET 222
TABLE 224 MICROCARRIERS MARKET FOR CELL BANKS, BY REGION, 2021–2028 (USD MILLION) 223
TABLE 225 NORTH AMERICA: MICROCARRIERS MARKET FOR CELL BANKS, BY COUNTRY, 2021–2028 (USD MILLION) 223
TABLE 226 EUROPE: MICROCARRIERS MARKET FOR CELL BANKS, BY COUNTRY, 2021–2028 (USD MILLION) 223
TABLE 227 ASIA PACIFIC: MICROCARRIERS MARKET FOR CELL BANKS, BY COUNTRY, 2021–2028 (USD MILLION) 224
TABLE 228 LATIN AMERICA: MICROCARRIERS MARKET FOR CELL BANKS, BY COUNTRY, 2021–2028 (USD MILLION) 224
TABLE 229 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR CELL BANKS, BY REGION, 2021–2028 (USD MILLION) 224
9 MICROCARRIERS MARKET, BY REGION 225
9.1 INTRODUCTION 226
TABLE 230 MICROCARRIERS MARKET, BY REGION, 2021–2028 (USD MILLION) 226
9.2 NORTH AMERICA 226
FIGURE 32 NORTH AMERICA: MICROCARRIERS MARKET SNAPSHOT 227
TABLE 231 NORTH AMERICA: MICROCARRIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 227
TABLE 232 NORTH AMERICA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 228
TABLE 233 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 234 NORTH AMERICA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 235 NORTH AMERICA: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 236 NORTH AMERICA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 237 NORTH AMERICA: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 238 NORTH AMERICA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 230
TABLE 239 NORTH AMERICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 240 NORTH AMERICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 231
TABLE 241 NORTH AMERICA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 231
9.2.1 US 231
9.2.1.1 Rising regulatory approvals for cell & therapy products to drive market 231
FIGURE 33 MARKET DEVELOPMENT FOR ADVANCED THERAPEUTIC MEDICINAL PRODUCTS (ATMPS) (USD BILLION) (EXCLUSIVE OF VACCINES) 232
TABLE 242 US: EXAMPLES OF LEADING SUCCESSFUL APPLICANTS IN CIRM’S TRANSLATIONAL PROGRAM 233
TABLE 243 US: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 234
TABLE 244 US: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 245 US: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 246 US: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 247 US: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 248 US: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 249 US: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 236
TABLE 250 US: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 251 US: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 237
TABLE 252 US: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 237
9.2.2 CANADA 237
9.2.2.1 Rising demand for biologics to drive market 237
TABLE 253 CANADA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 238
TABLE 254 CANADA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 238
TABLE 255 CANADA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 256 CANADA: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 257 CANADA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 258 CANADA: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 259 CANADA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 240
TABLE 260 CANADA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 261 CANADA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 241
TABLE 262 CANADA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 241
9.2.3 NORTH AMERICA: RECESSION IMPACT 241
9.3 EUROPE 242
TABLE 263 EUROPE: MICROCARRIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 242
TABLE 264 EUROPE: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 242
TABLE 265 EUROPE: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 266 EUROPE: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 267 EUROPE: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 268 EUROPE: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 269 EUROPE: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 270 EUROPE: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 244
TABLE 271 EUROPE: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 245
TABLE 272 EUROPE: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 245
TABLE 273 EUROPE: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 245
9.3.1 GERMANY 246
9.3.1.1 Rising R&D investments in life sciences research to propel market 246
TABLE 274 GERMANY: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 246
TABLE 275 GERMANY: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 276 GERMANY: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 277 GERMANY: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 278 GERMANY: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 249
TABLE 279 GERMANY: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 249
TABLE 280 GERMANY: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 249
TABLE 281 GERMANY: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 250
TABLE 282 GERMANY: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 250
TABLE 283 GERMANY: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 250
9.3.2 UK 251
9.3.2.1 Growing focus on oncology therapeutics to boost demand 251
TABLE 284 UK: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 253
TABLE 285 UK: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 286 UK: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 287 UK: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 254
TABLE 288 UK: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 254
TABLE 289 UK: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 254
TABLE 290 UK: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 255
TABLE 291 UK: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 292 UK: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 255
TABLE 293 UK: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 256
9.3.3 FRANCE 256
9.3.3.1 Rising focus on biotech clusters to boost demand 256
TABLE 294 FRANCE: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 257
TABLE 295 FRANCE: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 296 FRANCE: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 297 FRANCE: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 298 FRANCE: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 299 FRANCE: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 259
TABLE 300 FRANCE: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 259
TABLE 301 FRANCE: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 259
TABLE 302 FRANCE: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 260
TABLE 303 FRANCE: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 260
9.3.4 ITALY 260
9.3.4.1 Rising demand for therapeutics to propel market 260
TABLE 304 ITALY: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 261
TABLE 305 ITALY: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 261
TABLE 306 ITALY: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 307 ITALY: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 308 ITALY: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 309 ITALY: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 263
TABLE 310 ITALY: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 263
TABLE 311 ITALY: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 263
TABLE 312 ITALY: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 264
TABLE 313 ITALY: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 264
9.3.5 SPAIN 264
9.3.5.1 Increasing demand for biopharmaceuticals to support market growth 264
TABLE 314 SPAIN: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 265
TABLE 315 SPAIN: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 265
TABLE 316 SPAIN: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 266
TABLE 317 SPAIN: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 266
TABLE 318 SPAIN: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 266
TABLE 319 SPAIN: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 320 SPAIN: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 267
TABLE 321 SPAIN: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 322 SPAIN: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 268
TABLE 323 SPAIN: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 268
9.3.6 REST OF EUROPE 268
TABLE 324 REST OF EUROPE: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 269
TABLE 325 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 269
TABLE 326 REST OF EUROPE: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 270
TABLE 327 REST OF EUROPE: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 270
TABLE 328 REST OF EUROPE: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 271
TABLE 329 REST OF EUROPE: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 271
TABLE 330 REST OF EUROPE: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 271
TABLE 331 REST OF EUROPE: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 271
TABLE 332 REST OF EUROPE: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 272
TABLE 333 REST OF EUROPE: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 272
9.3.7 EUROPE: RECESSION IMPACT 273
9.4 ASIA PACIFIC 273
FIGURE 34 ASIA PACIFIC: MICROCARRIERS MARKET SNAPSHOT 274
TABLE 334 ASIA PACIFIC: MICROCARRIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 275
TABLE 335 ASIA PACIFIC: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 275
TABLE 336 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 275
TABLE 337 ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 338 ASIA PACIFIC: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 339 ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 340 ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 277
TABLE 341 ASIA PACIFIC: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 277
TABLE 342 ASIA PACIFIC: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 277
TABLE 343 ASIA PACIFIC: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 278
TABLE 344 ASIA PACIFIC: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 278
9.4.1 CHINA 278
9.4.1.1 Growth in bioprocessing industry to drive market 278
FIGURE 35 BIOPLAN SURVEY RESPONDENTS FOR ENTRY OF GLOBAL SUPPLIERS (2018−2021) 279
TABLE 345 CHINA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 280
TABLE 346 CHINA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 280
TABLE 347 CHINA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 280
TABLE 348 CHINA: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 349 CHINA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 350 CHINA: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 351 CHINA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 282
TABLE 352 CHINA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 282
TABLE 353 CHINA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 282
TABLE 354 CHINA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 283
9.4.2 JAPAN 283
9.4.2.1 Favorable regulatory support for drug discovery & development to drive market 283
TABLE 355 JAPAN: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 284
TABLE 356 JAPAN: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 284
TABLE 357 JAPAN: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 285
TABLE 358 JAPAN: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 285
TABLE 359 JAPAN: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 285
TABLE 360 JAPAN: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 286
TABLE 361 JAPAN: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 286
TABLE 362 JAPAN: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 286
TABLE 363 JAPAN: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 287
TABLE 364 JAPAN: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 287
9.4.3 INDIA 287
9.4.3.1 Rising pharmaceutical R&D spending to propel market 287
TABLE 365 INDIA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 288
TABLE 366 INDIA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 289
TABLE 367 INDIA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 289
TABLE 368 INDIA: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 289
TABLE 369 INDIA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 290
TABLE 370 INDIA: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 290
TABLE 371 INDIA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 290
TABLE 372 INDIA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 291
TABLE 373 INDIA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 291
TABLE 374 INDIA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 291
9.4.4 SOUTH KOREA 292
9.4.4.1 Rising demand for biosimilars to support market growth 292
TABLE 375 SOUTH KOREA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 293
TABLE 376 SOUTH KOREA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 293
TABLE 377 SOUTH KOREA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 293
TABLE 378 SOUTH KOREA: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 294
TABLE 379 SOUTH KOREA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 294
TABLE 380 SOUTH KOREA: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 294
TABLE 381 SOUTH KOREA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 295
TABLE 382 SOUTH KOREA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 295
TABLE 383 SOUTH KOREA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 295
TABLE 384 SOUTH KOREA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 296
9.4.5 REST OF ASIA PACIFIC 296
TABLE 385 REST OF ASIA PACIFIC: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 297
TABLE 386 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 297
TABLE 387 REST OF ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 297
TABLE 388 REST OF ASIA PACIFIC: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 298
TABLE 389 REST OF ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 298
TABLE 390 REST OF ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 299
TABLE 391 REST OF ASIA PACIFIC: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 299
TABLE 392 REST OF ASIA PACIFIC: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 299
TABLE 393 REST OF ASIA PACIFIC: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 300
TABLE 394 REST OF ASIA PACIFIC: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 300
9.4.6 ASIA PACIFIC: RECESSION IMPACT 300
9.5 LATIN AMERICA 301
TABLE 395 LATIN AMERICA: MICROCARRIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 301
TABLE 396 LATIN AMERICA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 301
TABLE 397 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 302
TABLE 398 LATIN AMERICA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 302
TABLE 399 LATIN AMERICA: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 302
TABLE 400 LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 303
TABLE 401 LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 303
TABLE 402 LATIN AMERICA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 303
TABLE 403 LATIN AMERICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 304
TABLE 404 LATIN AMERICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 304
TABLE 405 LATIN AMERICA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 304
9.5.1 BRAZIL 305
9.5.1.1 Rising focus on vaccine development to support market growth 305
TABLE 406 BRAZIL: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 305
TABLE 407 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 306
TABLE 408 BRAZIL: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 306
TABLE 409 BRAZIL: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 306
TABLE 410 BRAZIL: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 307
TABLE 411 BRAZIL: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 307
TABLE 412 BRAZIL: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 307
TABLE 413 BRAZIL: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 308
TABLE 414 BRAZIL: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 308
TABLE 415 BRAZIL: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 308
9.5.2 MEXICO 309
9.5.2.1 Expansion of pharma & biopharma companies to boost demand 309
TABLE 416 MEXICO: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 309
TABLE 417 MEXICO: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 309
TABLE 418 MEXICO: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 310
TABLE 419 MEXICO: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 310
TABLE 420 MEXICO: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 310
TABLE 421 MEXICO: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 311
TABLE 422 MEXICO: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 311
TABLE 423 MEXICO: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 311
TABLE 424 MEXICO: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 312
TABLE 425 MEXICO: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 312
9.5.3 REST OF LATIN AMERICA 312
TABLE 426 REST OF LATIN AMERICA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 313
TABLE 427 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 313
TABLE 428 REST OF LATIN AMERICA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 313
TABLE 429 REST OF LATIN AMERICA: MICROCARRIERS BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 314
TABLE 430 REST OF LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 314
TABLE 431 REST OF LATIN AMERICA: BIOREACTORS, BY TYPE, 2021–2028 (USD MILLION) 315
TABLE 432 REST OF LATIN AMERICA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 315
TABLE 433 REST OF LATIN AMERICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 315
TABLE 434 REST OF LATIN AMERICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 316
TABLE 435 REST OF LATIN AMERICA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 316
9.5.4 LATIN AMERICA: RECESSION IMPACT 316
9.6 MIDDLE EAST & AFRICA 317
TABLE 436 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET, BY REGION, 2021–2028 (USD MILLION) 317
TABLE 437 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 317
TABLE 438 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 318
TABLE 439 MIDDLE EAST & AFRICA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 318
TABLE 440 MIDDLE EAST & AFRICA: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 319
TABLE 441 MIDDLE EAST & AFRICA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 319
TABLE 442 MIDDLE EAST & AFRICA: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 320
TABLE 443 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 320
TABLE 444 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 320
TABLE 445 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 321
TABLE 446 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 321
9.6.1 MIDDLE EAST 322
9.6.1.1 Favorable government investments for biotech research to boost demand 322
TABLE 447 MIDDLE EAST: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 322
TABLE 448 MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 323
TABLE 449 MIDDLE EAST: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 323
TABLE 450 MIDDLE EAST: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 323
TABLE 451 MIDDLE EAST: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 324
TABLE 452 MIDDLE EAST: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 324
TABLE 453 MIDDLE EAST: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 324
TABLE 454 MIDDLE EAST: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 325
TABLE 455 MIDDLE EAST: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 325
TABLE 456 MIDDLE EAST: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 325
9.6.2 AFRICA 326
9.6.2.1 Rising government focus on clinical trial approvals to support market 326
TABLE 457 AFRICA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 326
TABLE 458 AFRICA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 327
TABLE 459 AFRICA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION) 327
TABLE 460 AFRICA: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION) 327
TABLE 461 AFRICA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 328
TABLE 462 AFRICA: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 328
TABLE 463 AFRICA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 328
TABLE 464 AFRICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION) 329
TABLE 465 AFRICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION) 329
TABLE 466 AFRICA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION) 329
9.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT 330
10 COMPETITIVE LANDSCAPE 331
10.1 OVERVIEW 331
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 331
FIGURE 36 MICROCARRIERS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 332
10.3 REVENUE SHARE ANALYSIS 333
FIGURE 37 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN MICROCARRIERS MARKET (2018–2022) 333
10.4 MARKET SHARE ANALYSIS 333
FIGURE 38 MICROCARRIERS MARKET SHARE, BY KEY PLAYER (2022) 334
TABLE 467 MICROCARRIERS MARKET: INTENSITY OF COMPETITIVE RIVALRY 334
10.5 COMPANY EVALUATION MATRIX 336
10.5.1 STARS 336
10.5.2 EMERGING LEADERS 336
10.5.3 PERVASIVE PLAYERS 336
10.5.4 PARTICIPANTS 336
FIGURE 39 MICROCARRIERS MARKET: COMPANY EVALUATION MATRIX (2022) 337
10.5.5 COMPANY FOOTPRINT ANALYSIS 338
TABLE 468 MICROCARRIERS MARKET: PRODUCT FOOTPRINT ANALYSIS (2022) 339
TABLE 469 MICROCARRIERS MARKET: REGIONAL FOOTPRINT ANALYSIS (2022) 340
10.6 START-UP/SME EVALUATION MATRIX 341
10.6.1 PROGRESSIVE COMPANIES 341
10.6.2 RESPONSIVE COMPANIES 341
10.6.3 DYNAMIC COMPANIES 341
10.6.4 STARTING BLOCKS 341
FIGURE 40 MICROCARRIERS MARKET: START-UP/SME EVALUATION MATRIX (2022) 342
10.6.5 COMPETITIVE BENCHMARKING OF START-UPS/SMES 343
TABLE 470 MICROCARRIERS MARKET: DETAILED LIST OF KEY START-UPS/SMES 343
TABLE 471 MICROCARRIERS MARKET: PRODUCT & REGIONAL FOOTPRINT ANALYSIS OF KEY START-UPS/SMES 344
10.7 COMPETITIVE SCENARIOS AND TRENDS 345
TABLE 472 MICROCARRIERS MARKET: KEY PRODUCT LAUNCHES (JANUARY 2020−OCTOBER 2023) 345
TABLE 473 MICROCARRIERS MARKET: KEY DEALS (JANUARY 2020−OCTOBER 2023) 346
TABLE 474 MICROCARRIERS MARKET: OTHER DEVELOPMENTS (JANUARY 2020−OCTOBER 2023) 347
11 COMPANY PROFILES 349
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
11.1 KEY PLAYERS 349
11.1.1 THERMO FISHER SCIENTIFIC INC. 349
TABLE 475 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 349
FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 350
11.1.2 SARTORIUS AG 357
TABLE 476 SARTORIUS AG: BUSINESS OVERVIEW 357
FIGURE 42 SARTORIUS AG: COMPANY SNAPSHOT (2022) 358
11.1.3 DANAHER CORPORATION 365
TABLE 477 DANAHER CORPORATION: BUSINESS OVERVIEW 365
FIGURE 43 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 366
11.1.4 MERCK KGAA 374
TABLE 478 MERCK KGAA: BUSINESS OVERVIEW 374
FIGURE 44 MERCK KGAA: COMPANY SNAPSHOT (2022) 375
11.1.5 CORNING INCORPORATED 381
TABLE 479 CORNING INCORPORATED: BUSINESS OVERVIEW 381
FIGURE 45 CORNING INCORPORATED: COMPANY SNAPSHOT (2022) 382
11.1.6 FUJIFILM HOLDINGS CORPORATION 387
TABLE 480 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW 387
FIGURE 46 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022) 388
11.1.7 BECTON, DICKINSON AND COMPANY (BD) 390
TABLE 481 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 390
FIGURE 47 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 391
11.1.8 EPPENDORF SE 393
TABLE 482 EPPENDORF SE: BUSINESS OVERVIEW 393
FIGURE 48 EPPENDORF SE: COMPANY SNAPSHOT (2022) 394
11.1.9 LONZA 397
TABLE 483 LONZA: BUSINESS OVERVIEW 397
FIGURE 49 LONZA: COMPANY SNAPSHOT (2022) 398
11.1.10 GETINGE AB 401
TABLE 484 GETINGE AB: BUSINESS OVERVIEW 401
FIGURE 50 GETINGE AB: COMPANY SNAPSHOT (2022) 402
11.1.11 CHEMOMETEC 404
TABLE 485 CHEMOMETEC: BUSINESS OVERVIEW 404
FIGURE 51 CHEMOMETEC: COMPANY SNAPSHOT (2022) 405
11.1.12 ESCO LIFESCIENCES GROUP LTD. 407
TABLE 486 ESCO LIFESCIENCES GROUP LTD.: BUSINESS OVERVIEW 407
11.1.13 ENTEGRIS 410
TABLE 487 ENTEGRIS: BUSINESS OVERVIEW 410
FIGURE 52 ENTEGRIS: COMPANY SNAPSHOT (2022) 411
11.1.14 BBI-BIOTECH GMBH 413
TABLE 488 BBI-BIOTECH GMBH: BUSINESS OVERVIEW 413
11.2 OTHER PLAYERS 414
11.2.1 STEMCELL TECHNOLOGIES 414
TABLE 489 STEMCELL TECHNOLOGIES: BUSINESS OVERVIEW 414
11.2.2 STOBBE GROUP 415
TABLE 490 STOBBE GROUP: BUSINESS OVERVIEW 415
11.2.3 DISTEK, INC. 417
TABLE 491 DISTEK, INC.: BUSINESS OVERVIEW 417
11.2.4 BIONET 418
TABLE 492 BIONET: BUSINESS OVERVIEW 418
11.2.5 G&G TECHNOLOGIES, INC. 419
TABLE 493 G&G TECHNOLOGIES, INC.: BUSINESS OVERVIEW 419
11.2.6 TANTTI 420
TABLE 494 TANTTI: BUSINESS OVERVIEW 420
11.2.7 KÜHNER AG 421
TABLE 495 KÜHNER AG: BUSINESS OVERVIEW 421
11.2.8 PBS BIOTECH, INC. 422
TABLE 496 PBS BIOTECH, INC.: BUSINESS OVERVIEW 422
11.2.9 REPROCELL INC. 423
TABLE 497 REPROCELL INC.: BUSINESS OVERVIEW 423
11.2.10 MEISSNER FILTRATION PRODUCTS, INC. 424
TABLE 498 MEISSNER FILTRATION PRODUCTS, INC.: BUSINESS OVERVIEW 424
11.2.11 SMART MCS PTY LTD 425
TABLE 499 SMART MCS PTY LTD: BUSINESS OVERVIEW 425
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX 426
12.1 DISCUSSION GUIDE 426
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 430
12.3 CUSTOMIZATION OPTIONS 432
12.4 RELATED REPORTS 432
12.5 AUTHOR DETAILS 433